# FDA Inspection 1214734 - Granules India Limited - June 23, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/granules-india-limited/96ab2c6e-db9a-4d70-8d0e-24ef942a2a3b
Source feed: FDA_Inspections

> FDA Inspection 1214734 for Granules India Limited on June 23, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1214734
- Company Name: Granules India Limited
- Inspection Date: 2023-06-23
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1047594 - 2018-03-23](https://www.globalkeysolutions.net/records/fda_inspections/granules-india-limited/753771aa-2bd9-4830-8756-bd297cb2cb2b)
- [FDA Inspection 954648 - 2015-12-18](https://www.globalkeysolutions.net/records/fda_inspections/granules-india-limited/c467edad-839c-4834-89b2-386274f3f7e9)
- [FDA Inspection 832632 - 2013-05-08](https://www.globalkeysolutions.net/records/fda_inspections/granules-india-limited/9eb89292-89e0-48a5-88a0-78cb02d9d423)
- [FDA Inspection 574854 - 2009-03-06](https://www.globalkeysolutions.net/records/fda_inspections/granules-india-limited/acfaf0a3-14ba-4565-80c1-5b145a6a1687)

Company: https://www.globalkeysolutions.net/companies/granules-india-limited/cdb2aa54-4375-4df2-8142-93321bdc2e2d

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c